BLAQclouds, Inc. Announces Strategic Partnership Agreement with Metavesco, Inc. to Accelerate Token Development and Web3 Community Growth

BLAQclouds, Inc. Announces Strategic Partnership Agreement with Metavesco, Inc. to Accelerate Token Development and Web3 Community Growth GlobeNewswire November 17, 2025 ROBESONIA, Pa., Nov. 17, 2025 (GLOBE NEWSWIRE) — BLAQclouds, Inc. (OTC: BCDS), a leading Web3 infrastructure and digital asset technology company, today announced the execution of a Strategic Partnership Agreement with Metavesco, Inc. (OTC: […]

J & J Snack Foods Reports Fiscal 2025 Fourth Quarter and Full-Year Results

J & J Snack Foods Reports Fiscal 2025 Fourth Quarter and Full-Year Results GlobeNewswire November 17, 2025 Fourth quarter Operating Income of $11.5 million and Adjusted Operating Income of $37.7 million Fourth quarter Net Earnings of $11.4 million and Adjusted EBITDA of $57.4 million Fourth quarter EPS of $0.58 and Adjusted EPS of $1.58 MOUNT

Angiex Completes Financings Totaling $31 Million to Advance Phase 1 Dose Escalation of Nuclear-Delivered ADC AGX101 in Patients with Advanced Solid Tumors

Angiex Completes Financings Totaling $31 Million to Advance Phase 1 Dose Escalation of Nuclear-Delivered ADC AGX101 in Patients with Advanced Solid Tumors Proceeds support ongoing all-comers Phase 1 trial of TM4SF1-directed Nuclear-Delivered ADC AGX101 GlobeNewswire November 17, 2025 CAMBRIDGE, Mass., Nov. 17, 2025 (GLOBE NEWSWIRE) — Angiex Inc., a developer of Nuclear-Delivered Antibody-Drug Conjugate(TM) (ND-ADC)

Diamond Equity Research Releases Update Note on Ensysce Biosciences, Inc. (NASDAQ: ENSC)

Diamond Equity Research Releases Update Note on Ensysce Biosciences, Inc. (NASDAQ: ENSC) GlobeNewswire November 17, 2025 New York, Nov. 17, 2025 (GLOBE NEWSWIRE) — Diamond Equity Research, a leading equity research firm with a focus on small capitalization public companies has released an Update Note on Ensysce Biosciences, Inc. (NASDAQ: ENSC). The research summary below

LUFA says no to government interference in free collective bargaining

LUFA says no to government interference in free collective bargaining GlobeNewswire November 17, 2025 SUDBURY, Ontario, Nov. 17, 2025 (GLOBE NEWSWIRE) — The Laurentian University Faculty Association (LUFA) announced that it is launching a Charter challenge under the Canadian Charter of Rights and Freedoms against the Government of Ontario for interfering with its free and

Avantor, Inc. Sued for Securities Law Violations – Contact the DJS Law Group to Discuss Your Rights – AVTR

Avantor, Inc. Sued for Securities Law Violations – Contact the DJS Law Group to Discuss Your Rights – AVTR GlobeNewswire November 17, 2025 LOS ANGELES, Nov. 17, 2025 (GLOBE NEWSWIRE) — The DJS Law Group reminds investors of a class action lawsuit against Avantor, Inc. (“Avantor” or “the Company”) (NYSE: AVTR) for violations of §§10(b)

Porosome Therapeutics Publishes Preclinical Findings Demonstrating Restoration of Neuronal Secretion and Reversal of Alzheimer’s Disease Pathology Following Porosome Reconstitution Therapy

Porosome Therapeutics Publishes Preclinical Findings Demonstrating Restoration of Neuronal Secretion and Reversal of Alzheimer's Disease Pathology Following Porosome Reconstitution Therapy GlobeNewswire November 17, 2025 Human brain organoid studies demonstrated significant improvement in neuronal growth, morphology, and function These findings highlight the potential of the porosome – a central node in cellular communication – as a

Gabelli Launches New Exchange-Traded Fund: Gabelli High Income ETF (GBHI)

Gabelli Launches New Exchange-Traded Fund: Gabelli High Income ETF (GBHI) GBHI to invest in high yield corporate bonds, investment-grade, hybrid or equity-related securities GlobeNewswire November 17, 2025 GREENWICH, Conn., Nov. 17, 2025 (GLOBE NEWSWIRE) — Gabelli Funds, LLC (“Gabelli”), a global asset management firm with over 45 years of experience managing client assets, today announced

FDA Accepts Supplemental New Drug Application for Arcutis’ ZORYVE(R) (roflumilast) Cream 0.3% for the Treatment of Plaque Psoriasis in Children Ages 2 to 5

FDA Accepts Supplemental New Drug Application for Arcutis' ZORYVE(R) (roflumilast) Cream 0.3% for the Treatment of Plaque Psoriasis in Children Ages 2 to 5 GlobeNewswire November 17, 2025 Prescription Drug User Fee Act (PDUFA) target action date set for June 29, 2026 If approved, ZORYVE cream 0.3% would be the first and only topical PDE4

Maxus Mining Initiates Historical Desktop Compilation on Four Critical Minerals Projects in British Columbia, Canada

Maxus Mining Initiates Historical Desktop Compilation on Four Critical Minerals Projects in British Columbia, Canada GlobeNewswire November 17, 2025 VANCOUVER, British Columbia, Nov. 17, 2025 (GLOBE NEWSWIRE) — Maxus Mining Inc. (“Maxus” or the “Company”) (CSE: MAXM | FRA: R7V), is pleased to announce it has commenced a historical drillhole compilation program (the “Program“) across

Scroll to Top